Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Gene Therapy Moratorium topic
No spam. Unsubscribe anytime.
Senator Shippey’s RS31966 would impose temporary moratorium on certain experimental gene-therapy immunizations
Summary
Senator Brandon Shippey asked the Senate Health and Welfare Committee to print RS31966, the "Doug Cameron Act," to impose a temporary moratorium on experimental human gene-therapy products used as immunizations for infectious disease indications; the committee voted to send the RS to print and sponsors said experts will be invited to the hearing.
Senator Brandon Shippey introduced RS31966, described in committee as a temporary moratorium on the use of experimental human gene-therapy products as immunizations for infectious disease indications.
"This legislation is named in honor of Doug Cameron, an Idaho rancher whose life was forever changed after receiving a genetic immunization," Shippey said, recounting the personal story offered in the bill text and arguing the state should pause to review safety and long-term effects.
Shippey told the committee the moratorium would provide time for a thorough review of safety and long-term effects and said the legislation contains an exemption noted on the bill's second page. He asked the committee to print the RS for future hearing and discussion.
Senator Melissa Wintrow asked substantive questions about the scope of the moratorium, including whether the bill would allow individuals to consent to specific treatments and what infectious-disease indications would be covered. Shippey said the full committee hearing will include experts who can address those questions and that the sponsor would be prepared to answer detailed questions at that time.
Senator Lenny moved to send RS31966 to print; the motion was seconded and approved by voice vote. The transcript includes no committee opposition on the motion.
Next steps: RS31966 will be printed for formal introduction and scheduled for a committee hearing where sponsors said they will invite expert testimony to explain the bill's scope and exemptions.
